Mendaera vs Idexx Laboratories

Side-by-side comparison of AI visibility scores, market position, and capabilities

Mendaera logo

Mendaera

EmergingHealthcare

AI-Guided Robotic Systems for Minimally Invasive Procedures

Mendaera is developing robotic systems that combine real-time imaging and AI guidance to enable minimally invasive procedures with greater precision and speed; raised $100M in a 2024 Series B led by GV and Bessemer;

About

Mendaera is a San Francisco-based medical technology company developing a new class of robotic systems designed to make minimally invasive procedures faster, more precise, and more accessible across a broader range of clinical settings. The company's platform integrates real-time imaging — including ultrasound and CT fluoroscopy — with AI-powered guidance and robotic actuation to assist clinicians performing needle-based interventions such as biopsies, fluid drainage, nerve blocks, and targeted drug delivery. By automating the most technically demanding aspects of needle placement, Mendaera's system aims to reduce procedure time, decrease complication rates, and enable procedures to be performed at the bedside or in community hospitals rather than exclusively in specialized interventional suites.

Full profile
Idexx Laboratories logo

Idexx Laboratories

LeaderHealthcare Tech

Enterprise

Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.

AI VisibilityBeta
Overall Score
A94
Category Rank
#19 of 290
AI Consensus
71%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
92
Gemini
88

About

IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.

Full profile

Key Details

Category
AI-Guided Robotic Systems for Minimally Invasive Procedures
Enterprise
Tier
Emerging
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.